Pharmacoeconomical Analysis of Pazufloxacin and Levofloxacin in Treatment of Urinary Tract Infection
Abstract
Objective:To analyze the cost-effectiveness of pazufloxacin and levofloxacin in treatment of urinary tract infection. Methods: 70 cases with urinary infection were randomly divided into 2 groups,in which they were treated with pazufloxacin and levofloxacin, respectively. The cost-effectiveness in two groups was analyzed and compared with each other by pharmacoeconomical methods. Results: There was no significant diffe-rence in therapeutic effect between two groups(P0.05),such as effective rates of 94.3% and 88.6%,bacterial clearance rates of 91.4% and 85.7% and undesired event rates of 5.71% and 8.57% in pazufloxacin group and levofloxacin group.However,there was significant difference in cost-effectiveness ratio between two group,16.96 and 9.30 respectively in pazufloxacin group and levofloxacin group (P0.05). Conclusion: Levofloxacin has cost-effective advantage over pazufloxacin in the treatment of urinary tract infection.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.